Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Hester Biosciences Ltd.

Hester Biosciences

NSE

0.00

0.00 (0.00)%

Healthcare

Small-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

1. Rajiv Gandhi
Managing Director & Chief Executive Officer
4. Ameet Desai
Non Executive Independent Director
5. Anil Jain
Non Executive Independent Director
6. Jatin Trivedi
Non Executive Independent Director
7. Vinod Mali
Company Secretary & Compliance Officer
8. Priya Gandhi
Executive Director
9. Sanjiv Gandhi
Promoter & Non-Executive Director
10. Ravin Gandhi
Promoter & Non-Executive Director
11. Nina Gandhi
Alternate Director

Contact Information

Company Address

Meda Adraj , Kadi, ,
Mehsana, Gujarat - 384441
www.hester.in
mail@hester.in

Registrar

MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009
Phone:
Email:
Website: https://in.mpms.mufg.com/

Company Profile

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company
Enrich money logo